Multidisciplinary approach for the treatment of head and neck cancer Masato Fujii Introduction to Review Articles 13 February 2014 Pages: 209 - 210
Is biomarker research advancing in the era of personalized medicine for head and neck cancer? Tomoya Yokota Review Article 21 January 2014 Pages: 211 - 219
Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer Masato Fujii Review Article 28 February 2014 Pages: 220 - 229
Clinicopathological correlation for the role of fluorodeoxyglucose positron emission tomography computed tomography in detection of choroidal malignant melanoma Toshihiko MatsuoYuka OginoMitsumasa Kaji Original Article 01 March 2013 Pages: 230 - 239
A matched-pair comparison of intensity-modulated radiation therapy with cetuximab versus intensity-modulated radiation therapy with platinum-based chemotherapy for locally advanced head neck cancer Jiayi HuangAndrew M. BaschnagelDaniel Krauss Original Article 12 March 2013 Pages: 240 - 246
Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsil Sung Hak LeeEun Ji ChoiChang Suk Kang Original Article 04 April 2013 Pages: 247 - 253
CD133 expression: a potential prognostic marker for non-small cell lung cancers Hidenori MizugakiJun Sakakibara-KonishiMasaharu Nishimura Original Article 12 March 2013 Pages: 254 - 259
Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis Naohiro WatanabeHiroyuki TaniguchiYoshinori Hasegawa Original Article 17 April 2013 Pages: 260 - 265
Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer Taichiro GotoArafumi MaeshimaRyoichi Kato Original Article 10 May 2013 Pages: 266 - 273
Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancer Yasuhiro SuzukiRin OgiyaYutaka Tokuda Original Article 05 April 2013 Pages: 274 - 279
Clinicopathologic characteristics and survival of male breast cancer Dongying LiuGuangru XieMing Chen Original Article 03 May 2013 Pages: 280 - 287
Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients Thomas ThomaidisArndt WeinmannThe Upper-GI-Group of AIO (Arbeitsgemeinschaft Internistische Onkologie), Germany Original Article 27 March 2013 Pages: 288 - 296
Safety and efficacy of nimotuzumab in combination with radiotherapy for patients with squamous cell carcinoma of the esophagus Ning-Yi MaXu-Wei CaiKuai-Le Zhao Original Article 21 May 2013 Pages: 297 - 302
Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer Yiting GengXiaofeng ChenYongmei Yin Original Article 10 May 2013 Pages: 303 - 311
Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer: long-term follow-up results Masahiro MorimotoFumiaki IsohashiKazuhiko Ogawa Original Article 01 June 2013 Pages: 312 - 318
Overexpression of AIB1 correlates inversely with E-cadherin expression in pancreatic adenocarcinoma and may promote lymph node metastasis Si GuoJingJing XuHaiBo Yu Original Article 30 March 2013 Pages: 319 - 324
A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder Zhulin YangZhi YangSenlin Chen Original Article 17 April 2013 Pages: 325 - 335
A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix Eriko TakatoriTadahiro ShojiToru Sugiyama Original Article 14 March 2013 Pages: 336 - 340
Feasibility of extended-field irradiation and intracavitary brachytherapy combined with weekly cisplatin chemosensitization for IB2–IIIB cervical cancer with positive paraaortic or high common iliac lymph nodes: a retrospective review Shiho KujiYasuyuki HirashimaTetsuo Nishimura Original Article 02 April 2013 Pages: 341 - 347
Outcome of stage IB2–IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy Kazunori UegakiMuneaki ShimadaJunzo Kigawa Original Article 17 April 2013 Pages: 348 - 353
Curcumin targets the AKT–mTOR pathway for uterine leiomyosarcoma tumor growth suppression Tze Fang WongTakashi TakedaNobuo Yaegashi Original Article 11 May 2013 Pages: 354 - 363
Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker Yutaka IhataEtsuko MiyagiFumiki Hirahara Original Article 23 May 2013 Pages: 364 - 372
Prognostic implication of infiltrative growth pattern and establishment of novel risk stratification model for survival in patients with upper urinary tract urothelial carcinoma Takeshi HashimotoJun NakashimaMasaaki Tachibana Original Article 03 April 2013 Pages: 373 - 378
Pathological outcomes of Japanese men eligible for active surveillance after radical prostatectomy Takahiro InoueHidefumi KinoshitaTadashi Matsuda Original Article 03 April 2013 Pages: 379 - 383
Multiple primary malignancies in elderly patients with high-grade soft tissue sarcoma Eiji KozawaHideshi SugiuraYoshihiro Nishida Original Article 20 March 2013 Pages: 384 - 390
Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia Takashi ShibataYosuke MinamiYuichi Ando Original Article 23 April 2013 Pages: 391 - 396
Usefulness of one-point plasma SN-38G/SN-38 concentration ratios as a substitute for UGT1A1 genetic information after irinotecan administration Kouichi HiroseKoushiro YamashitaYorinobu Maeda Original Article 19 April 2013 Pages: 397 - 402
Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials Wei-Xiang QiLi-Na TangZan Shen Original Article 20 April 2013 Pages: 403 - 410
